article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

article thumbnail

Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients

NORML

“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cancer patients medicate with cannabis with or without clinical trials

Cannabis Life Network

Every year sees a pile of scientific research supporting the use of cannabis as a treatment for cancer. Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. 1, 2) Before legalization in […]. 1, 2) Before legalization in […].

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. There could be a role for cannabinoids in the management of tinnitus through their anticonvulsant effects. And its conclusion?

article thumbnail

Cannabinoids for Scleroderma

Project CBD

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma.

article thumbnail

Chanelle McCoy Granted Approval For Significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial

Cannabis Law Report

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

article thumbnail

The Science Behind Medical Marijuana: Exploring Cannabinoids and Their Therapeutic Effects

MMJ Recs

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.